Humana Inc. $HUM Shares Newly Acquired by Simplify Asset Management Inc.

Key Points

• Simplify Asset Management acquired 65,190 Humana shares worth approximately $24.9 million in the third quarter, making HUM about 0.4% of its portfolio. Institutional investors collectively own 92.38% of Humana.
• Humana reported quarterly earnings of $7.61 per share, beating estimates of $7.27, while revenue rose 26.2% year over year to $40.89 billion.
• Analysts maintain a “Moderate Buy” consensus rating with an average price target of $453.30; Humana also declared a quarterly dividend of $0.885 per share, representing a 0.9% yield.

Simplify Asset Management Inc. purchased a new position in shares of Humana Inc. (NYSE:HUM - Free Report) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 65,190 shares of the insurance provider's stock, valued at approximately $24,875,000. Humana makes up about 0.4% of Simplify Asset Management Inc.'s holdings, making the stock its 13th biggest holding.

A number of other institutional investors have also modified their holdings of the company. BlackRock Inc. acquired a new stake in Humana during the second quarter worth approximately $4,138,160,000. Pzena Investment Management LLC purchased a new stake in Humana in the 2nd quarter worth approximately $1,749,014,000. Assenagon Asset Management S.A. raised its holdings in Humana by 20,126.8% in the 3rd quarter. Assenagon Asset Management S.A. now owns 1,255,479 shares of the insurance provider's stock valued at $479,053,000 after acquiring an additional 1,249,272 shares during the last quarter. Legal & General Group Plc acquired a new position in Humana in the 2nd quarter valued at $329,760,000. Finally, Barrow Hanley Mewhinney & Strauss LLC purchased a new position in shares of Humana during the 2nd quarter worth $314,922,000. Institutional investors and hedge funds own 92.38% of the company's stock.

Humana Stock Performance

Shares of HUM stock opened at $411.36 on Thursday. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62. The company has a market cap of $49.40 billion, a PE ratio of 38.92, a P/E/G ratio of 2.60 and a beta of 0.74. The company's fifty day simple moving average is $399.48 and its 200-day simple moving average is $307.32. Humana Inc. has a 52 week low of $163.11 and a 52 week high of $456.50.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping analysts' consensus estimates of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The firm had revenue of $40.89 billion during the quarter, compared to analysts' expectations of $40.58 billion. During the same period in the prior year, the company earned $6.27 EPS. The firm's revenue was up 26.2% on a year-over-year basis. As a group, equities research analysts anticipate that Humana Inc. will post 9.03 EPS for the current year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 27th. Stockholders of record on Friday, October 30th will be given a $0.8850 dividend. The ex-dividend date of this dividend is Friday, October 30th. This represents a $3.54 annualized dividend and a dividend yield of 0.9%. Humana's dividend payout ratio is presently 33.49%.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. Robert W. Baird set a $596.00 price objective on Humana and gave the stock an "outperform" rating in a report on Friday, October 9th. Truist Financial lifted their price objective on Humana from $415.00 to $475.00 and gave the company a "hold" rating in a research report on Monday, October 12th. Piper Sandler upgraded Humana from a "hold" rating to an "overweight" rating and set a $463.00 target price for the company in a research note on Thursday, July 30th. Deutsche Bank Aktiengesellschaft started coverage on Humana in a research report on Thursday, July 30th. They set a "hold" rating on the stock. Finally, Royal Bank Of Canada increased their target price on Humana from $246.00 to $415.00 and gave the stock a "sector perform" rating in a research report on Thursday, July 9th. Twenty-one analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $453.30.

Humana Profile

Humana Inc is a health and well-being company that provides insurance products and health care services in the United States and Puerto Rico. The company's primary business is government-sponsored health coverage, particularly Medicare Advantage plans for older adults, along with Medicare prescription drug plans, Medicaid coverage and certain commercial health insurance products.

Humana also operates CenterWell, its health care services platform focused on older adults. CenterWell includes primary care clinics, home health services and pharmacy services, with an emphasis on coordinated care, chronic-condition management and helping members receive care in lower-cost settings.

Founded in 1961 as a nursing-home company, Humana expanded into hospital operations before shifting its focus toward health insurance and related services.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.